Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
progression once in post to £62,728 Grade: 8 Full Time, Permanent Closing date: 18th August 2025 Academic Development Programme - new Assistant Professors will undertake a 5-year development programme, at
-
, and celebrate their success. We are committed to helping the people who work here to develop through our sector-leading Birmingham Professional programme which provides all professional services staff
-
that are innovative to the subject area or institution; leading on curriculum design at module and programme level to ensure it is contemporary, inclusive, engaging and academically challenging; actively engaging
-
to £55,755 with potential progression once in post to £62,728 Grade: 8 Full Time, Fixed Term contract up to May 2026 Closing date: 25th August 2025 Academic Development Programme - new Assistant Professors
-
. The Postdoctoral Research Fellow will: Conduct a programme of research towards achieving one or more these goals. This will include contributing to the design of experiments, growth of the necessary plant material
-
date: 19th June 2025 Background To create and contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research
-
processes Contribute to the planning and organising of the research programme and/or specific research project Co-ordinate own work with others to avoid conflict or duplication of effort Knowledge
-
sector-leading Birmingham Professional programme which provides all professional services staff with development opportunities and the encouragement to reach their full potential. With almost 5,000
-
the city and beyond, support them to succeed, and celebrate their success. We are committed to helping the people who work here to develop through our sector-leading Birmingham Professional programme which
-
target for patients with cirrhosis and hepatocellular cancer. The project is part of a larger research programme to identify new immunotherapies for liver disease and cancer within the Shetty group